The FDA's drug approval rate plunged in 2016

2016 was not a good year for new medicines. The U.S. Food and Drug Administration cleared just 22 new drugs for sale last year, the lowest number since 2010 and a sharp decline from 2015's total of 45 approved drugs. While the FDA simply delayed approval on some applications that will likely be given the green light in 2017, there's also been a decline in applications overall, Reuters reports. Despite recent advances in cancer treatment and other genetic diseases, drug companies are finding difficulty securing financial returns due to political pushback against the rising costs of medicine. Returns on research and development investment at the top 12 pharmaceutical companies fell to 3.7 percent in 2016, from a high of 10.1 percent in 2010.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Spaniards seeing red over bullfighting
Under the Radar Shock resignation of top matador is latest blow in culture war over tradition that increasingly divides Spain
-
Bailouts: Why Trump is rescuing Argentina
Feature The White House approved a $20 billion currency swap with Argentina
-
James indictment: Trump’s retribution
Feature Trump pursues charges against Letitia James in revenge for her civil fraud lawsuit
-
Gold tops $4K per ounce, signaling financial unease
Speed Read Investors are worried about President Donald Trump’s trade war
-
Electronic Arts to go private in record $55B deal
speed read The video game giant is behind ‘The Sims’ and ‘Madden NFL’
-
New York court tosses Trump's $500M fraud fine
Speed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in Intel
Speed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to China
Speed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with Disney
Speed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B deal
Speed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
FCC greenlights $8B Paramount-Skydance merger
Speed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance